Trial intelligence / Profile preview

Neuronox vs Dysport for Cervical Dystonia

NCT03805152Phase 3Completed

Sponsor
Ministry of Public Health
Start
Oct 2019
Primary completion
Jan 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in cervical dystonia (CD), sponsored by Ministry of Public Health. Started Oct 2019; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

cervical dystonia (CD)

Beyond the preview

Go deeper on NCT03805152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03805152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call